Testing Hypotheses of Covariate-Adaptive Randomized Clinical Trials

被引:55
作者
Ma, We [1 ]
Hu, Feifang [2 ]
Zhang, Lixin [3 ]
机构
[1] Univ Virginia, Dept Stat, Charlottesville, VA 22904 USA
[2] George Washington Univ, Dept Stat, Washington, DC 20052 USA
[3] Zhejiang Univ, Dept Math, Hangzhou 310006, Zhejiang, Peoples R China
基金
美国国家科学基金会;
关键词
Conservative tests; Linear models; Pocock and Simon's marginal procedure; Power; Stratified permuted block design; Type I error; CELL LUNG-CANCER; ASYMPTOTIC PROPERTIES; GEMCITABINE PLUS; ALLOCATION; DESIGNS; STRATIFICATION; POWER;
D O I
10.1080/01621459.2014.922469
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
Covariate-adaptive designs are often implemented to balance important covariates in clinical trials. However, the theoretical properties of conventional testing hypotheses are usually unknown under covariate-adaptive randomized clinical trials. In the literature, most studies are based on simulations. In this article, we provide theoretical foundation of hypothesis testing under covariate-adaptive designs based on linear models. We derive the asymptotic distributions of the test statistics of testing both treatment effects and the significance of covariates under null and alternative hypotheses. Under a large class of covariate-adaptive designs, (i) the hypothesis testing to compare treatment effects is usually conservative in terms of small Type I error; (ii) the hypothesis testing to compare treatment effects is usually more powerful than complete randomization; and (iii) the hypothesis testing for significance of covariates is still valid. The class includes most of the covariate-adaptive designs in the literature; for example, Pocock and Simon's marginal procedure, stratified permuted block design, etc. Numerical studies are also performed to assess their corresponding finite sample properties. Supplementary material for this article is available online.
引用
收藏
页码:669 / 680
页数:12
相关论文
共 38 条
[1]   A Simulation Study of the Validity and Efficiency of Design-Adaptive Allocation to Two Groups in the Regression Situation [J].
Aickin, Mikel .
INTERNATIONAL JOURNAL OF BIOSTATISTICS, 2009, 5 (01)
[2]   Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomized trial with quality of life as the primary outcome [J].
Anderson, H. ;
Hopwood, P. ;
Stephens, R. J. ;
Thatcher, N. ;
Cottier, B. ;
Nicholson, M. ;
Milroy, R. ;
Maughan, T. S. ;
Falk, S. J. ;
Bond, M. G. ;
Burt, P. A. ;
Connolly, C. K. ;
McIllmurray, M. B. ;
Carmichael, J. .
BRITISH JOURNAL OF CANCER, 2000, 83 (04) :447-453
[3]   Clinical assessment incorporating a personal genome [J].
Ashley, Euan A. ;
Butte, Atul J. ;
Wheeler, Matthew T. ;
Chen, Rong ;
Klein, Teri E. ;
Dewey, Frederick E. ;
Dudley, Joel T. ;
Ormond, Kelly E. ;
Pavlovic, Aleksandra ;
Morgan, Alexander A. ;
Pushkarev, Dmitry ;
Neff, Norma F. ;
Hudgins, Louanne ;
Gong, Li ;
Hodges, Laura M. ;
Berlin, Dorit S. ;
Thorn, Caroline F. ;
Sangkuhl, Katrin ;
Hebert, Joan M. ;
Woon, Mark ;
Sagreiya, Hersh ;
Whaley, Ryan ;
Knowles, Joshua W. ;
Chou, Michael F. ;
Thakuria, Joseph V. ;
Rosenbaum, Abraham M. ;
Zaranek, Alexander Wait ;
Church, George M. ;
Greely, Henry T. ;
Quake, Stephen R. ;
Altman, Russ B. .
LANCET, 2010, 375 (9725) :1525-1535
[4]   OPTIMUM BIASED COIN DESIGNS FOR SEQUENTIAL CLINICAL-TRIALS WITH PROGNOSTIC FACTORS [J].
ATKINSON, AC .
BIOMETRIKA, 1982, 69 (01) :61-67
[5]   TREATMENT ALLOCATION PROCEDURE FOR SEQUENTIAL CLINICAL-TRIALS [J].
BEGG, CB ;
IGLEWICZ, B .
BIOMETRICS, 1980, 36 (01) :81-90
[6]   ADAPTIVE ALLOCATION IN RANDOMIZED CONTROLLED TRIALS [J].
BIRKETT, NJ .
CONTROLLED CLINICAL TRIALS, 1985, 6 (02) :146-155
[7]   Covariate-adjusted response-adaptive designs for generalized linear models [J].
Cheung, Siu Hung ;
Zhang, Li-Xin ;
Hu, Feifang ;
Chan, Wai Sum .
JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2014, 149 :152-161
[8]   FORCING A SEQUENTIAL EXPERIMENT TO BE BALANCED [J].
EFRON, B .
BIOMETRIKA, 1971, 58 (03) :403-&
[9]   ROLE OF PROGNOSTIC STRATIFICATION IN PREVENTING BIAS PERMITTED BY RANDOM ALLOCATION OF TREATMENT [J].
FEINSTEIN, AR ;
LANDIS, JR .
JOURNAL OF CHRONIC DISEASES, 1976, 29 (04) :277-284
[10]   VALIDITY AND POWER OF TESTS WHEN GROUPS HAVE BEEN BALANCED FOR PROGNOSTIC FACTORS [J].
FORSYTHE, AB .
COMPUTATIONAL STATISTICS & DATA ANALYSIS, 1987, 5 (03) :193-200